Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  London Stock Exchange  >  GlaxoSmithKline plc    GSK   GB0009252882

Delayed Quote. Delayed  - 02/12 11:35:19 am
1363.5 GBp   +1.34%
02/12 GLAXOSMITHKLINE : TOP NEWS SUMMARY: UK Regulator Fines GlaxoSmithKli..
02/12 UK watchdog fines GSK $54 million over 'pay-for-delay' drug deals
02/12DJGLAXOSMITHKLINE : Glaxo Fined $53 Million in Generic Drug Delay Ruli..
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Income Statement Evolution
Annual Income Statement Data
Actuals in M GBP Estimates in M GBP
Fiscal Period December 201320142015201620172018
Sales26 50523 00623 92324 89925 67926 731
Operating income (EBITDA)8 8838 0457 0288 0528 6259 085
Operating profit (EBIT)8 0156 5945 7296 4206 9157 364
Pre-Tax Profit (EBT)6 6472 96810 5265 0045 8296 492
Net income5 6282 7568 4222 6913 2403 882
P/E ratio0,150,240,0825,920,717,2
EPS (PNC )11156,717252,565,879,4
Dividend per Share (PNC )78,080,080,082,080,481,4
Yield484%581%583%6,01%5,89%5,97%
Reference price (PNC )16.113.813.71363.51363.51363.5
Announcement Date02/05/2014
12:00pm
02/04/2015
03:18pm
02/03/2016
12:00pm
---
Finances - Leverage
Actuals in M GBP Estimates in M GBP
Fiscal Period December 201320142015201620172018
Debt12 64514 37710 72711 96512 01112 259
Finance------
Operating income (EBITDA)8 8838 0457 0288 0528 6259 085
Leverage
(Debt/EBITDA)
1,42x1,79x1,53x1,49x1,39x1,35x
Capital Expenditure1 1881 1881 3801 6971 4781 483
Book Value Per Share (BVPS)146 PNC87,6 PNC106 PNC93,5 PNC92,0 PNC81,7 PNC
Cash Flow per Share149 PNC108 PNC53,2 PNC105 PNC123 PNC142 PNC
Announcement Date02/05/2014
12:00pm
02/04/2015
03:18pm
02/03/2016
12:00pm
---
Balance Sheet Analysis
Assessed data source :
© 2016 Thomson Reuters
Advertisement
Financial Ratios

Size 2016e 2017e
Capitalization 66 404 M GBP -
Entreprise Value (EV) 78 369 M GBP 78 414 M GBP
Valuation 2016e 2017e
P/E ratio (Price / EPS) 25,9x 20,7x
Capitalization / Revenue 2,67x 2,59x
EV / Revenue 3,15x 3,05x
EV / EBITDA 9,73x 9,09x
Yield (DPS / Price) 6,01% 5,89%
Price to book (Price / BVPS) 14,6x 14,8x
Profitability 2016e 2017e
Operating Margin (EBIT / Sales) 25,8% 26,9%
operating Leverage (Delta EBIT / Delta Sales) 2,95x 2,46x
Net Margin (Net Profit / Revenue) 10,8% 12,6%
ROA (Net Profit / Asset) 6,72% 8,54%
ROE (Net Profit / Equities) 79,3% 204%
Rate of Dividend 156% 122%
Balance Sheet Analysis 2016e 2017e
CAPEX / Sales   6,82% 5,76%
Cash Flow / Sales 20,6% 23,3%
Capital Intensity (Assets / Sales) 1,61x 1,48x
Financial Leverage (Net Debt / EBITDA) 1,49x 1,39x
Price Earning Ratio Help 
The blue ligne is the average P/E ratio (without estimates)
EPS & Dividend